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Abstract Plasmin, the enzymatically active form of plasmino-
gen, can activate several matrix metalloproteinases (MMPs). In
this study, we investigated the activation of MMP-1, one of the
major interstitial collagenases, by plasmin which was generated
on the surface of Staphylococcus aureus cells. Plasmin bound to
plasminogen receptors on S. aureus degraded the major 125I-
labeled 55-kDa proMMP-1 into the 42-kDa form corresponding
to the size of active MMP-1. MMP-1 formed by S. aureus-
bound plasmin was also enzymatically active as judged by
digestion of the synthetic collagenase substrate, DNP-Pro-Leu-
Gly-Leu-Trp-Ala-D-Arg-NH2. The finding that, in MMP-1
molecules generated either by soluble plasmin or by S. aureus-
bound plasmin, the amino-terminal amino acid sequences were
identical indicated that the activation mechanisms of the two
plasmin forms do not differ from each other. The present
observations emphasise and broaden the physiological impor-
tance of bacterial plasminogen receptors. In addition to direct
proteolytic effects on components of the extracellular matrix,
receptor-bound plasmin is also capable of initiating an MMP-1-
dependent matrix-degrading enzymatic cascade.
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1. Introduction
Several Gram-positive and Gram-negative invasive bacteria
express speci¢c receptors for plasminogen, the zymogen form
of the serine-protease plasmin (for a review, see [1]). These
bacteria include the following: Staphylococcus aureus [2],
group A, B, C and G streptococci [3^6], Escherichia coli
[7,8], Salmonella enterica [9], Neisseria gonorrhoeae, Neisseria
meningitidis [10], Haemophilus in£uenzae [10], as well as Bor-
relia burgdorferi [11,12] and Helicobacter pylori [13], the caus-
ative agents of Lyme disease and gastritis, respectively. The
physiological relevance of plasminogen binding to the recep-
tors on bacterial surfaces is highlighted by ¢ndings demon-
strating that receptor-bound plasminogen can be activated
into plasmin which is protected against the major plasmin
inhibitor, K2-antiplasmin [2,11]. The best characterised bacte-
rial plasminogen receptors are streptococcal enolase and M-
like protein on the surface of group A streptococci [14^16],
type 1 and type G ¢mbria and curly structures of E. coli and
of S. enterica [17^19], the aspartase-related 55-kDa protein of
H. in£uenzae [20], and the outer surface protein A and the 70-
kDa protein of B. burgdorferi [11].
It has been shown that E. coli and Salmonella degrade ex-
tracellular matrix (ECM) and penetrate arti¢cial basement
membranes at an enhanced rate when these bacteria have
receptor-bound plasmin on their surfaces [9,21,22]. Moreover,
B. burgdorferi with active plasmin bound to their surface plas-
minogen receptors cause a more severe form of bacteraemia
than their counterparts without active plasmin [23]. These
¢ndings emphasise the importance of plasmin-mediated pro-
teolytic events in invasion of bacteria through the ECM.
Physiological degradation of ECM is an integral part of
tissue remodelling that takes place in both physiological and
pathological conditions. ECM is also essential for the main-
tenance of connective tissue in adult organisms [24]. The deg-
radation of ECM is regulated by the balance between the
production of matrix-degrading enzymes and their inhibitors.
One of the major matrix metalloproteinase (MMP) involved
in the degradation of collagens is the interstitial collagenase or
matrix metalloprotease-1 (MMP-1). It cleaves ¢brillar type I,
II, III, VII and X collagens at a single site [25]. MMP-1 is
secreted as a major 53-kDa non-glycosylated and as a minor
57-kDa glycosylated form which can be activated by SH-re-
acting and denaturing agents, as well as by many proteases
such as trypsin and plasmin to produce active 42-kDa and 47-
kDa forms, respectively [26]. In this study we show that plas-
min on the surface of S. aureus is able to activate the major
interstitial collagenase, MMP-1, thus enabling more e⁄cient
bacterial penetration and invasion of tissues.
2. Materials and methods
2.1. Reagents
Glu-plasminogen, Glu-plasmin and chromogenic substrate S-2251
(H-D-valyl-L-leucyl-L-lysine-p-nitroanilide hydrochloride) were pur-
chased from Kabi Vitrum. Aprotinin, K2-antiplasmin, phenylmethyl-
sulphonyl £uoride (PMSF), and 3-cyclohexylamino-1-propane sul-
fonic acid (CAPS) were from Sigma. Trypsin (sequencing grade)
was from Promega. Single-chain tissue-type plasminogen activator
(tPA, containing roughly 10% two-chain form) was obtained from
American Diagnostics (New York, NY) and Super RX medical X-
ray ¢lm from Fuji. MMP-1 was puri¢ed from phorbol-treated U937
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cells using sequential chromatography on CM-52 and DEAE/red
Sepharose as described [27]. Synthetic substrate (DNP-Pro-Leu-Gly-
Leu-Trp-Ala-D-Arg-NH2) was used for testing of collagenase activity
of MMP-1.
2.2. Iodination of MMP-1
MMP-1 was iodinated by the iodogen method [28] as described in
detail [2] using an incubation time of 1 min.
2.3. Cultivation of bacteria
S. aureus, strain Newman, was grown in Todd-Hewitt broth for 16^
18 h at 37‡C on a shaker, collected by centrifugation, washed twice
with phosphate-bu¡ered saline (PBS) containing 0.02% (v/w) sodium
azide and ¢nally suspended in plain Tris-BSA bu¡er (50 mM Tris, pH
7.5, 0.1% (w/v) bovine serum albumin) or in bu¡er additionally con-
taining 5 mM CaCl2 (Tris/CaCl-BSA). The concentration of bacteria
was determined spectrophotometrically and adjusted to 2U1010 bac-
terial cells/ml.
2.4. Generation of plasmin on the surface of S. aureus
Surface-bound plasmin on S. aureus was generated as described [2].
Brie£y, 5U109 bacteria were incubated on a shaker for 1.5 h at 20‡C
in various combinations of 25 Wg of Glu-plasminogen, 25 ng of tPA
and 2.5 Wg of K2-antiplasmin in a reaction volume of 1 ml of Tris-BSA
bu¡er. After incubation the bacteria were collected by centrifugation
at 3800Ug for 10 min, washed twice with Tris bu¡er and ¢nally
suspended in 250 Wl of Tris-BSA bu¡er. Formation of active plasmin
was tested with a chromogenic assay [2] by incubating the bacteria
(1.6U109) with 10 Wl of 4 mM S-2251 for 2 h at 20‡C. Subsequently,
optical densities in the supernatants were recorded at 405 nm after
removal of the bacteria from the suspensions by centrifugation.
2.5. Processing of MMP-1 by S. aureus-bound plasmin
S. aureus cells (1.6U109, 50 Wl) having surface-bound plasmin were
incubated with 150 pg of 125I-MMP-1 (50 Wl) for 4 h at 37‡C. The
treatment was stopped by adding 50 Wl of Laemmli sample bu¡er
containing L-mercaptoethanol [29] and by boiling the samples imme-
diately. Finally, the samples were analysed in 12% SDS-PAGE [29]
followed by autoradiography on X-ray ¢lm.
2.6. Collagenase activity of MMP-1 modi¢ed by S. aureus-bound
plasmin
To test the collagenase activity of MMP-1 modi¢ed by bacteria-
bound plasmin, 1.25 Wg of MMP-1 in 250 Wl of Tris bu¡er was ¢rst
treated with 5U109 S. aureus cells having surface-bound plasmin for
24 h at 37‡C in the presence of 5 Wg of K2-antiplasmin. As positive
control the same amount of MMP-1 in 250 Wl of Tris bu¡er was
treated with 3 Wg of trypsin for 15 min at 37‡C. As the negative
control, similar incubations were done in the absence of MMP-1
but in the presence of either plain S. aureus cells or cells having sur-
face-bound plasmin. The incubations were stopped by adding 10 Wl of
57 mM PMSF into the reactions followed by removal of bacteria by
centrifugation. Subsequently, collagenase activity in the incubation
medium was tested by reaction with the synthetic collagenase sub-
strate, DNP-Pro-Leu-Gly Leu-Trp-Ala-D-Arg-NH2. Cleavage prod-
ucts were separated by reverse phase chromatography, and quanti-
tated by monitoring the UV absorbance at 214 nm [30,31].
2.7. Cleavage of MMP-1 by S. aureus-bound plasmin
To compare the cleavage mechanism of S. aureus-bound plasmin
with that of soluble plasmin, proMMP-1 (30 Wg) was treated in 100 Wl
Tris bu¡er containing 5 mM CaCl2 either with 109 S. aureus cells
having surface-bound plasmin or with 300 pg of soluble plasmin.
Samples (60 Wl) were taken after 30 and 120 min of incubation at
37‡C. After incubation with S. aureus, the incubation mixtures were
centrifuged to remove the bacteria. 50 Wl of each supernatant was
mixed with 25 ml of 50% sample bu¡er [29], boiled immediately
and lyophilised. Subsequently, the lyophilised samples were solubilised
in 35 ml of H2O, separated on 15% SDS-PAGE followed by electro-
phoretic transfer onto ProBlott-PVFD membrane in 10 mM CAPS
bu¡er, pH 11, containing 10% methanol [32]. Proteins on the mem-
brane were visualised by Coomassie brilliant blue staining, and the
bands of interest were cut out and subjected to N-terminal sequencing
(Procise 494 HT, Applied Biosystems, Perkin Elmer, CA, USA).
3. Results
3.1. Generation of plasmin on the surface of S. aureus and
processing of MMP-1 by S. aureus-bound plasmin
Plasmin activity on the staphylococcal surface was meas-
ured by reacting S. aureus cells with the chromogenic sub-
strate S-2251 after incubation of bacteria with Glu-plasmino-
gen, tPA and K2-antiplasmin in various combinations.
Bacteria alone or in combination with Glu-plasminogen
were unable to generate functional plasmin (Fig. 1, upper
panel). A strong bacteria-associated plasmin activity was gen-
erated after incubation of the staphylococci with Glu-plasmi-
nogen and tPA. Presence of the plasmin inhibitor K2-antiplas-
min in the incubation medium did not signi¢cantly decrease
the enzymatic activity. Processing of 125I-proMMP-1 by bac-
teria-bound plasmin was detected by SDS-PAGE analysis and
subsequent autoradiography. The proMMP-1 which had been
incubated with S. aureus cells in the absence or presence of
Glu-plasminogen migrated as a major 55-kDa band (Fig. 1,
lower panel). Incubation of 125I-proMMP-1 under conditions
able to generate active plasmin (see upper panel) resulted in
conversion of the major 55-kDa species into the 42-kDa one,
i.e. the size of active MMP-1. Comparison of the cleavage
sites of MMP-1 by soluble plasmin and plasmin associated
with S. aureus was done by analysing the splitting products
Fig. 1. Upper panel: Plasminogen activation on S. aureus surface.
S. aureus cells were incubated in either the absence or presence of
various combinations of Glu-plasminogen (plg), tPA, and K2-anti-
plasmin (K2-AP), as indicated. After incubation for 90 min the bac-
teria were washed, and plasmin activity associated with bacteria was
measured by incubating the bacteria with the chromogenic substrate
S-2251, and by monitoring the absorbance at 405 nm. For experi-
mental details, see Section 2. Lower panel: Processing of proMMP-
1 by S. aureus. 125I-proMMP-1 was incubated with S. aureus in var-
ious combinations with Glu-plasminogen, tPA and K2-antiplasmin
as above. After incubation for 4 h, the samples were analysed by re-
ducing SDS-PAGE with subsequent autoradiography. Migration of
molecular weight markers is shown on the left. The upper and lower
arrows indicate the 52-kDa proMMP-1 and the 42-kDa MMP-1, re-
spectively. For experimental details, see Section 2.
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of MMP-1 and by determining the amino-terminal sequences.
As shown in Fig. 2, MMP-1 migrated to the same position
whether it had been cleaved by soluble or bacteria-bound
plasmin. In the two preparations of MMP-1, amino-terminal
sequence analyses revealed the sequence Leu-Lys-Val-Met-
Lys-Gln-Pro-Arg.
3.2. Collagenase activity of MMP-1 cleaved by
S. aureus-bound plasmin
To study collagenase activity of the cleaved MMP-1, deg-
radation of the synthetic substrate peptide, DNP-Pro-Leu-
Gly-Leu-Trp-Ala-D-Arg-NH2, was followed by HPLC analy-
sis after treatment of proMMP-1 with various activators
(trypsin served as a positive control). As seen in Fig. 3,
proMMP-1 could be activated by the S. aureus cells having
surface-bound plasmin whereas incubation of proMMP-1
with plain S. aureus cells failed to activate. Similarly, activa-
tion media lacking proMMP-1 were unable to generate any
collagenase activity.
4. Discussion
Activation of MMP-1 is a two-step process involving a
primary cleavage of the propeptide region followed by remov-
al of the remaining peptide by self-degradation [25]. Soluble
plasmin makes the initial cleavage of proMMP-1 at the Arg36-
Asn37 bond which is then followed by self-degradation at the
bond between Thr64 and Leu65 [26] leading to the fully con-
verted (42-kDa) active enzyme. In this study our aim was to
investigate whether plasmin which is bound to its receptor(s)
on the staphylococcal surface can activate MMP-1 like the
soluble plasmin.
To generate bacteria-bound plasmin, S. aureus cells were
incubated with Glu-plasminogen and tPA, and subsequently
the surface-associated plasmin activity was determined. Im-
portantly, the presence of K2-antiplasmin in the incubation
medium caused no signi¢cant decrease in generated plasmin
activity indicating that the plasmin formed was protected
against K2-antiplasmin. This, again, revealed that plasmin
was bound to the staphylococcal plasminogen receptors and
was not in soluble form in the reaction mixture. The results
agree with our previous ¢ndings demonstrating that binding
of Glu-plasminogen to S. aureus enhances its tPA-mediated
activation and leads to surface-bound plasmin activity which
is protected against K2-antiplasmin [2].
Processing of proMMP-1 was investigated by incubating
125I-proMMP-1 with S. aureus cells together with various
combinations of Glu-plasminogen, tPA, and K2-antiplasmin
and by monitoring its digestion by SDS-PAGE analysis and
subsequent autoradiography. This experimental design dem-
onstrated clearly that functional plasmin is required to process
proMMP-1 into a form corresponding to the size of the active
form of MMP-1. By using the substrate peptide DNP-Pro-
Leu-Gly-Leu-Trp Ala-D-Arg-NH2, it could be demonstrated
that MMP-1 was indeed enzymically active after having been
cleaved by S. aureus-bound plasmin.
Processing of the proMMP-1 by soluble or S. aureus-bound
plasmin appeared to proceed similarly. In SDS-PAGE MMP-
1 processed either way migrated to the same position and,
moreover, amino-terminal sequence analyses of the two prep-
arations revealed the sequence Leu-Lys-Val-Met-Lys-Gln-Pro-
Arg. Thus, both receptor-bound and soluble plasmin had pro-
duced the active enzyme where the ¢nal processing had oc-
curred between residues Thr64 and Leu65. No attempts were
made to determine the speci¢c activity of the MMP-1 acti-
vated by receptor-bound and soluble plasmin. Neither was the
cleavage site of the intermediate form of MMP-1 determined
which, in fact, would represent the initial cleavage site by
plasmin. However, since the end products had identical ami-
no-termini (Leu65) and MMP-1 did not bind to the staphylo-
coccal surface (data not shown), it is very likely that receptor-
bound and soluble plasmin will cleave MMP-1 at the same
site in the activation peptide. This is the ¢rst time receptor-
bound plasmin is shown to have a similar MMP-activating
e¡ect as soluble plasmin. One can envisage that solid-phase
plasmin has similar properties also on eukaryotic cell surfaces
and on other bacteria expressing receptors for plasminogen.
The pathophysiological relevance of the present ¢nding is that
plasmin activity generated on the staphylococcal surface, if in
a tissue environment in which the host cells produce MMP-1,
Fig. 2. Separation of proMMP-1 cleavage products for amino-termi-
nal sequencing. ProMMP-1 was incubated in plain bu¡er, in bu¡er
containing soluble plasmin or in bu¡er containing S. aureus cells
having surface-bound plasmin. After incubation for 120 min, the
bacteria were removed by centrifugation, and the supernatants were
subjected to SDS-PAGE, followed by electrotransfer to PVFD
membrane, with ensuing amino-terminal sequencing of the Coomas-
sie blue-stained protein bands. Migration of molecular weight
markers is shown on the left. Positions of proMMP-1 and MMP-1
are indicated on the right.
Fig. 3. Collagenase activity of MMP-1 cleaved by S. aureus-bound
plasmin. Synthetic substrate DNP-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-
NH2 was reacted with supernatants originating from activation mix-
tures. Cleavage products of the substrate peptide were analysed by
HPLC.
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provides S. aureus with a powerful additional proteolytic ma-
chinery besides the proteases secreted by the bacteria and the
direct proteolytic activities of the bacteria-associated plasmin.
The collagenolytic activity generated by staphylococci may
then help S. aureus to penetrate through basement membranes
and other structures of the extracellular matrix, and to escape
from abscesses.
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